Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia (Q31858009)

4 July 2017

Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia (English)

1 reference

4 July 2017

1 reference

6

März W

1 reference

4 July 2017

Hoffmann MM

1

1 reference

4 July 2017

Scharnagl H

2

1 reference

4 July 2017

Köster W

3

1 reference

4 July 2017

Winkler K

4

1 reference

4 July 2017

Wieland H

5

1 reference

4 July 2017

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

303

1 reference

4 July 2017

41-48

1 reference

4 July 2017

1-2

1 reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Genotyping and sequence analysis of apolipoprotein E isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Nucleotide sequence and structure of the human apolipoprotein E gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Inhibition of lipoprotein lipase by the receptor-binding domain of apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2800%2900372-7

10.1016/S0009-8981(00)00372-7

7 January 2021

Identifiers

DOI

1 reference

4 July 2017

1 reference